LARGE B-CELL LYMPHOMA (LBCL)
Clinical trials for LARGE B-CELL LYMPHOMA (LBCL) explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA (LBCL) trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA (LBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis study is testing an experimental drug called surovatamig for adults whose B-cell non-Hodgkin lymphoma has come back or stopped responding to at least two prior treatments. The main goals are to see if the drug can shrink the cancer and how safe it is for patients. Researcher…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New Two-Pronged immune therapy aims to outsmart aggressive lymphoma
Disease control Recruiting nowThis study is testing a new version of CAR-T cell therapy designed to attack lymphoma cells in two ways at once. It is for people whose large B-cell lymphoma has come back or hasn't responded to other treatments. The goal is to see if this dual-target approach is more effective a…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE2 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC